Table 1.
Baseline participant characteristics by hemodialysis status
| Characteristic | Awaiting Dialysis, n=110 | Recent Hemodialysis,a n=143 |
|---|---|---|
| Age, yr | 58 (11) | 54 (14) |
| Race | ||
| White | 72 (65) | 54 (38) |
| Black | 33 (30) | 73 (51) |
| Other | 5 (5) | 16 (11) |
| Men | 72 (65) | 97 (68) |
| Smoking | ||
| Current | 21 (19) | 24 (17) |
| Former | 48 (44) | 41 (29) |
| Never | 41 (37) | 78 (54) |
| History of diabetes | 73 (66) | 77 (54) |
| Prevalent cardiovascular disease | 58 (53) | 56 (39) |
| Dialysis duration, mo | NA | 4.6 (3) |
| Body mass index, kg/m2 | 32 (7) | 29 (8) |
| Systolic BP, mm Hg | 156 (20) | 152 (25) |
| Statin use | 69 (66) | 64 (46) |
| Niacin use | 2 (2) | 1 (1) |
| Fibrate use | 7 (7) | 3 (2) |
| Insulin use | 49 (47) | 45 (32) |
| eGFR, ml/min per 1.73 m2 | 13 (4) | NA |
| C-reactive protein,b mg/L | 3.4 (1.2–10.7) | 5.6 (2.9–23.8) |
| Uric acid, mg/dl | 7.8 (2.0) | 5.3 (1.7) |
| Albumin, g/dl | 3.6 (0.6) | 3.5 (0.7) |
| Hemoglobin, g/dl | 10.4 (1.6) | 10.3 (1.7) |
| Total cholesterol, mg/dl | 174 (52)c | 172 (42)d |
| HDL-C, mg/dl | 46 (14)c | 51 (17)d |
| Triglycerides, mg/dl | 180 (110)c | 144 (61)d |
Values are expressed as mean (SD) or number (percentage). NA, not applicable; HDL-C, HDL cholesterol.
a
The Hemodialysis Fistula Maturation Study participants who initiated hemodialysis within the previous year.
b
Values are expressed as median (interquartile range).
c
Values are missing for eight participants.
d
Values are missing for three participants.